Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
- Client
- Department of Health and Human Services
- RFP Number
- SW-120247
- Posted
- 10/1/2026
- Category
- Software, System and Application
- Budget
- Looking for Proposals
- NAICS
- 541714
- Set-aside
- —
- Contact
- The SURPASS Team
- [email protected]
Description
AI GeneratedThe buyer requires a vendor to provide a simulation-augmented, real-time platform. The requested scope involves establishing platform-level processes, documents, data structures, decision rules, and a governance framework to support concurrent intervention arms under a common operational structure. Vendors must perform the work offsite at their own office premises. Only USA organizations qualify as eligible bidders for this onshore opportunity. Vendors must submit a Scope of Work document following a specific template that details technical tasks, subtasks, milestones, deliverables, research involvement, and task timelines ranging from Month 1 through 60. The buyer is currently looking for proposals to establish the budget.
Official SAM.gov notice
- Solicitation number
- ARPA-H-SOL-26-164
- Agency
- Department of Health and Human Services
- Buying office
- National Institutes of Health › Advanced Research Projects Agency for Health (Arpa-H)
- Notice type
- Solicitation
- Responses due
- Nov 30, 2026, 5:00 PM ET
- Posted on SAM.gov
- Sep 30, 2026
- NAICS
- 541714 · Research and Development in Biotechnology (except Nanobiotechnology)
- Product/service code
- AN13
- Contracting contact
- The SURPASS Team
[email protected]
Read the official notice description
The Advanced Research Projects Agency for Health (ARPA-H) posts this solicitation in support of its Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) Program. ARPA-H anticipates multiple Other Transaction Agreement awards will result from this opportunity.
Interested parties are invited to review the attached Solicitation (ARPA-H-SOL-26-164) and associated attachments.
As detailed in Special Notice ARPA-H-SN-26-164, ARPA-H will host an informational webinar on 15 OCT 2026 and a 2-day Proposers’ Day on 6 and 9 NOV 2026 in support of SURPASS.
All questions related to SURPASS should be submitted to [email protected].
Source: SAM.gov contract opportunities data (U.S. federal public data).
Incumbent
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Research and Development in Biotechnology (except Nanobiotechnology)). This is not this requirement's award history.
Recent similar awards: Department of Health and Human Services, NAICS 541714
| Vendor and award | Value | Ends |
|---|---|---|
| AMGEN USA INC75A50122C00065 · TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MA | $839.9M | Sep 29, 2032 |
| 4J THERAPEUTICS INC75A50124C00052 · THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEMONSTRATE THE VERSATILITY AND EFFICACY OF O | $63.1M | Mar 31, 2032 |
| BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL75A50124C00033 · THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFE | $122.5M | Mar 31, 2032 |
| SRI INTERNATIONAL75N93026F00002 · TO AWARD TASK ORDER C03 | $722.0K | Feb 19, 2032 |
| ADVANCED TECHNOLOGY INTERNATIONAL75A50124F61007 · OT TASK ORDER 7-CENTRAL INFLUENZA AND EMERGING INFECTIOUS DISEASES VACCINE IMMUNOGENICITY | $13.0M | Sep 30, 2031 |
Top vendors in this category: Department of Health and Human Services, NAICS 541714, since Oct 1, 2024
1,124 contract awards in this NAICS over the period.
- 1. ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)$336.6M
- 2. AMGEN USA INC$215.9M
- 3. START2 GROUP, INC.$194.3M
- 4. SHIONOGI INC$156.1M
- 5. MAPP BIOPHARMACEUTICAL, INC.$133.1M
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.
Source and verification
Original sourceCraxy AI summarizes this opportunity from the original listing and available solicitation documents. Confirm submission instructions and amendments with the issuing source before responding.
Personalized fit score
Sign up free to see how well this opportunity fits your company — based on your saved profile.
Sign up to see your fit score